InspireMD, Inc.
(NYSE Amex Equities : NSPR)

( )
NSPR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-0.36%86.990.6%$601.67m
TMOThermo Fisher Scientific Inc.
0.05%240.781.0%$520.75m
ABTAbbott Laboratories
0.15%71.530.8%$488.96m
ISRGIntuitive Surgical, Inc.
-1.06%536.782.4%$449.04m
ALGNAlign Technology, Inc.
-1.79%216.166.3%$315.21m
BAXBaxter International Inc.
-1.35%69.681.7%$275.30m
BDXBecton, Dickinson and Company
-1.19%239.201.1%$274.30m
SYKStryker Corporation
-1.00%165.871.3%$257.72m
TFXTeleflex Incorporated
-0.16%257.505.4%$253.26m
BSXBoston Scientific Corporation
-1.11%37.271.1%$251.77m
EWEdwards Lifesciences Corporation
-0.07%168.301.2%$228.11m
DXCMDexCom, Inc.
0.87%150.828.5%$186.51m
ABMDABIOMED, Inc.
0.72%336.133.3%$175.58m
ZBHZimmer Biomet Holdings, Inc.
-1.36%103.911.7%$148.50m
COOCooper Companies, Inc.
-0.76%267.572.2%$117.59m

Company Profile

InspireMD, Inc. is a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.